Delivery Order SPE2DB22D2206-SPE2DB25FKD68
- Not listed
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Department of Defense's Medical Supply Chain awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 6, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with Defense Logistics Agency Troop Support...
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,270.52 to AmerisourceBergen Drug Corp for the supply of Talzenna 0.35 mg softgel capsules (30-count units) under a firm fixed-price contract. The contract, awarded on September 15, 2025, with completion targeted for October 6, 2025, represents a non-competitive delivery order placement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Talzenna 0.25 mg softgel capsules (30-count units) to support federal medical procurement needs. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $22,270.52 with an ultimate completion date of October 15, 2025. The award is funded by the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TALZENNA 0.35 mg softgel capsules (30-count supply) with a ceiling value of $11,135.25 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by October 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Talzenna 0.5 mg softgels (30-count units) under a firm fixed-price contract with a ceiling value of $11.1K. This delivery order, which has no set-aside designation, represents a competitive award and is due for completion by October 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support platform for military healthcare programs. AmerisourceBergen's role as a pharmaceutical prime vendor for the Defense Logistics Agency demonstrates its established capability to meet federal medical procurement requirements through competitive contracting. The company supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems, with contract awards reflecting consistent delivery of brand-name and generic pharmaceuticals across multiple therapeutic domains. This Talzenna delivery order exemplifies the routine pharmaceutical procurements executed through the company's existing prime vendor relationship with DLA, enabling efficient supply chain management for Department of Defense medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/28/25 |